Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Metformin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. Weight loss is recognized as a side effect of metformin, and many people who treat their ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Obesity rates have dropped alongside surging use of Ozempic, Wegovy and other blockbuster GLP-1 weight-loss drugs, a new report shows. The obesity rate for adults in the United States slid from a ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...